Answers are grounded in this paper and cite their sources.
We suggest that ROBO1 status forms as predictive biomarker of outcome in high-risk populations such as African-Americans and DOCK1-targeting therapy has a clinical potential for treating metastatic-CaP.
No takes yet. Share an insight, caveat, or question.
Ferrari et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: